DK481388A - Calciumtilskud - Google Patents

Calciumtilskud

Info

Publication number
DK481388A
DK481388A DK481388A DK481388A DK481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A DK 481388 A DK481388 A DK 481388A
Authority
DK
Denmark
Prior art keywords
calcium
grants
malate
citrate
excipients
Prior art date
Application number
DK481388A
Other languages
English (en)
Other versions
DK481388D0 (da
Inventor
Stephen Allen Jacobs
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK481388D0 publication Critical patent/DK481388D0/da
Publication of DK481388A publication Critical patent/DK481388A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK481388A 1987-08-28 1988-08-29 Calciumtilskud DK481388A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (2)

Publication Number Publication Date
DK481388D0 DK481388D0 (da) 1988-08-29
DK481388A true DK481388A (da) 1989-03-02

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481388A DK481388A (da) 1987-08-28 1988-08-29 Calciumtilskud

Country Status (13)

Country Link
EP (1) EP0304987B1 (da)
JP (1) JP2795651B2 (da)
KR (1) KR970009583B1 (da)
AT (1) ATE82120T1 (da)
AU (1) AU625809B2 (da)
CA (1) CA1314233C (da)
DE (1) DE3875867T2 (da)
DK (1) DK481388A (da)
HK (1) HK182096A (da)
IE (1) IE61452B1 (da)
IL (1) IL87452A (da)
NZ (1) NZ225950A (da)
ZA (1) ZA886355B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085008C (en) * 1990-06-14 1998-08-18 Mary M. Fox Calcium citrate malate composition
DE69233250T2 (de) * 1991-05-06 2004-08-26 The Procter & Gamble Company, Cincinnati Kombinationen aus calzium und vitamin d
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2123604C (en) * 1991-12-26 1998-02-17 Alice Lyles Burkes Storage stable calcium-supplemented beverage concentrates
AU5406094A (en) * 1992-10-21 1994-05-09 Procter & Gamble Company, The Sweetener containing a concentrated bioavailable calcium source
EP0788318B1 (en) * 1992-10-21 2000-12-20 The Procter & Gamble Company Concentrated bioavailable calcium source
EP0665720B1 (en) * 1992-10-21 1996-07-10 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品/冷蔵品およびその製造法
AU2007285386B2 (en) * 2006-08-17 2011-02-03 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
EP2051701A2 (en) * 2006-08-17 2009-04-29 The Procter and Gamble Company Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
JP2015500333A (ja) * 2011-12-13 2015-01-05 アモーフィカル リミテッド. カルシウム吸収不良及び代謝性骨障害を治療するための非晶質炭酸カルシウム
AU2016273058B2 (en) 2015-06-04 2021-05-20 Amorphical Ltd. Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates
IL266149B (en) 2016-10-25 2022-08-01 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia
MX2022000947A (es) 2019-07-23 2022-04-26 Amorphical Ltd Carbonato de calcio amorfo para mejorar el rendimiento deportivo.
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Also Published As

Publication number Publication date
NZ225950A (en) 1991-10-25
KR970009583B1 (en) 1997-06-14
AU625809B2 (en) 1992-07-16
IE61452B1 (en) 1994-11-02
IL87452A (en) 1992-07-15
ZA886355B (en) 1989-05-30
CA1314233C (en) 1993-03-09
JP2795651B2 (ja) 1998-09-10
KR890003391A (ko) 1989-04-14
HK182096A (en) 1996-10-11
JPH01156985A (ja) 1989-06-20
IL87452A0 (en) 1989-01-31
AU2159888A (en) 1989-06-15
EP0304987A2 (en) 1989-03-01
DE3875867D1 (de) 1992-12-17
IE882610L (en) 1989-02-28
EP0304987B1 (en) 1992-11-11
EP0304987A3 (en) 1990-02-21
ATE82120T1 (de) 1992-11-15
DE3875867T2 (de) 1993-04-01
DK481388D0 (da) 1988-08-29

Similar Documents

Publication Publication Date Title
DK481388D0 (da) Calciumtilskud
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
NZ221424A (en) Pharmaceutical compositions contaipyrimidines
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
GB2259647B (en) Medicaments for treating gastrointestinal disorders
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
GB8800276D0 (en) Medical treatment
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
ATE59550T1 (de) Chlorpheniramine therapie.
IT1224250B (it) Associzione del depiprazolo con la morfina
IL79207A0 (en) Pharmaceutical compositions containing terguide
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment